US Drug Recall Register

FDA Drug Recalls

11,815 recalls · Class II, newest first

Class II · Moderate risk Terminated

Cosopt

Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Cardinal Health Inc. D-0411-2021
Class II · Moderate risk Terminated

Atropine Sulfate Ophthalmic Solution

Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Cardinal Health Inc. NDC 17478-215-05 D-0410-2021
Class II · Moderate risk Terminated

Lidocaine HCL Visc 2% 100ml

Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Cardinal Health Inc. D-0409-2021
Class II · Moderate risk Terminated

Ofloxacin 0.3% 5ml Opth

Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Cardinal Health Inc. D-0408-2021
Class II · Moderate risk Terminated

Fenofibrate Capsules

Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Cardinal Health Inc. D-0407-2021
Class II · Moderate risk Terminated

Methocarbamol 500mg 500

Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Cardinal Health Inc. D-0406-2021
Class II · Moderate risk Terminated

Synthroid

Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Cardinal Health Inc. D-0405-2021
Class II · Moderate risk Terminated

Creon

Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Cardinal Health Inc. NDC 0032-3016-13 D-0402-2021
Class II · Moderate risk Terminated

Niacin 250mg 110

Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Cardinal Health Inc. D-0401-2021
Class II · Moderate risk Terminated

Therapeutic M 130

Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Cardinal Health Inc. D-0400-2021
Class II · Moderate risk Terminated

Ganirelix Acetate Injection

Reason Failed Impurities/Degradation Specifications

Sun Pharmaceutical Industries INC NDC 55566-1000-1 D-0320-2021
Class II · Moderate risk Terminated

ZOMA-Jet 10 Demonstration Kit

Reason Defective Delivery System: customer complaints concerning the injector pen breaking apart and disintegrating into pieces.

Ferring Pharmaceuticals Inc D-0318-2021
Class II · Moderate risk Terminated

ZOMA-Jet 5 Demonstration Kit

Reason Defective Delivery System: customer complaints concerning the injector pen breaking apart and disintegrating into pieces.

Ferring Pharmaceuticals Inc D-0317-2021
Class II · Moderate risk Terminated

Omeprazole Delayed-Release Capsules

Reason Failed Impurities/Degradation Specifications: Out-of-Specification results obtained for unknown impurities during stability testing.

Breckenridge Pharmaceutical, Inc NDC 51991-643-10 D-0308-2021
Class II · Moderate risk Terminated

Phenylephrine HCl Injection

Reason Lack of Assurance of Sterility: customer complaints of loose crimped vial overseals which may result in a non-sterile product.

Sagent Pharmaceuticals Inc D-0305-2021
Class II · Moderate risk Terminated

Durisan Antimicrobial Solutions

Reason CGMP Deviations: lots recalled due to CGMP deviations because they were manufactured under the same conditions as product lots found to be contaminated.

Sanit Technologies, LLC dba Durisan D-0659-2021
Class II · Moderate risk Terminated

Durisan Antimicrobial Solutions

Reason CGMP Deviations: lots recalled due to CGMP deviations because they were manufactured under the same conditions as product lots found to be contaminated.

Sanit Technologies, LLC dba Durisan D-0658-2021
Class II · Moderate risk Terminated

0.9% SODIUM CHLORIDE Irrigation

Reason Presence of particulate matter.one confirmed customer report of particulate matter within two semi-rigid bottles identified prior to use

ICU Medical Inc NDC 0990-7138-09 D-0313-2021
Class II · Moderate risk Terminated

Gabapentin Oral Solution

Reason Failed Impurities/Degradation Specifications; out of specification for unknown impurity observed during 6 month stability testing

Akorn, Inc. D-0301-2021
Class II · Moderate risk Terminated

Nortriptyline HCL capsules

Reason cGMP deviations: The quantity of active ingredient used for the product lot was inadvertently taken from an ingredient lot from an alternate supplier before that specific lot was formally qualified for use by the manufacturing site.

Direct Rx D-0300-2021
Class II · Moderate risk Terminated

Progesterone Capsules

Reason Failed Dissolution Specifications: Out-of-specification results observed for dissolution during stability testing.

Dr. Reddy's Laboratories, Inc. NDC 43598-350-01 D-0292-2021
Class II · Moderate risk Terminated

Daytrana

Reason Defective Delivery System: Out of specification for mechanical peel.

Noven Pharmaceuticals Inc NDC 68968-5555-3 D-0296-2021